Scientists who perform studies on medical marijuana won’t be getting any higher than the rest of us. The National Institute on Drug Abuse (NIDA), who supplies the drug, have received many complaints from researchers stating that the weed is far too weak to be compared with the substance that is being sold on the street.
The marijuana that is given to the research groups is currently grown in the University of Mississippi. In 2014 the cultivation program increased their production from 40lbs to 1,300lbs. Because of this, the NIDA increased their spending money by over 50%. Since then, the university has started to grow more strains and it is these strains that will be used in the new research. One of the new strains has very high levels of cannabidoil (CBD). This substance isn’t hallucinogenic, but it has proven to deliver therapeutic effects.
Even though the university is using different strains, it won’t be as strong as the stuff you can get on the streets or elsewhere. In fact, the strongest marijuana that the NIDA can provide is 12% and pot seized by the DEA quite often contains over 20%.
Regardless of this, researchers really do have to jump through hoops in order to gain access to the more expensive plants that are available. The NIDA charge them far more than clinically grown pot in Israel and Canada – however, soon this may all come to an end. A new bill would allow three FDA approved companies to cultivate pot for research purposes. This would discard the review process that adds years to the approval time of a study.